AssuredPartners Investment Advisors LLC Takes $297,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

AssuredPartners Investment Advisors LLC acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 990 shares of the company’s stock, valued at approximately $297,000.

A number of other institutional investors and hedge funds also recently modified their holdings of HCA. Congress Wealth Management LLC DE lifted its position in shares of HCA Healthcare by 3.4% in the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company’s stock valued at $312,000 after buying an additional 34 shares during the last quarter. Evergreen Private Wealth LLC boosted its position in HCA Healthcare by 0.3% during the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company’s stock worth $3,838,000 after purchasing an additional 35 shares during the period. Mediolanum International Funds Ltd lifted its stake in shares of HCA Healthcare by 0.3% during the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock worth $3,153,000 after buying an additional 36 shares during the last quarter. Prairie Wealth Advisors Inc. grew its stake in HCA Healthcare by 6.1% in the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock valued at $210,000 after buying an additional 40 shares during the last quarter. Finally, Whittier Trust Co. boosted its holdings in shares of HCA Healthcare by 3.6% during the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company’s stock worth $359,000 after acquiring an additional 41 shares during the period. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Down 0.0 %

Shares of HCA opened at $342.25 on Friday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The stock has a fifty day moving average of $324.53 and a 200-day moving average of $341.56. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The stock has a market capitalization of $84.26 billion, a price-to-earnings ratio of 15.58, a PEG ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the firm posted $5.90 earnings per share. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be paid a $0.72 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.84%. HCA Healthcare’s dividend payout ratio is presently 13.11%.

Insider Buying and Selling

In other news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.30% of the stock is owned by insiders.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Morgan Stanley reduced their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. KeyCorp decreased their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Barclays cut their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a report on Monday, January 27th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. Finally, Royal Bank of Canada dropped their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.